The network is delighted to introduce the ICC education programme course directors:NHS CLICC logo

  • Dr Rachel Bastiaenen, Clinical Lead for Inherited Cardiac Conditions and Consultant Cardiologist at Guy’s and St Thomas’​ NHS Foundation Trust
  • Prof Elijah Behr, Professor of Cardiovascular Medicine and Consultant Cardiologist and Electrophysiologist, St George’s University Hospitals NHS Foundation Trust
  • Dr Antonis Pantazis, Consultant Cardiologist at Royal Brompton & Harefield NHS Foundation Trust
  • Dr Leema Robert, Consultant Clinical Geneticist at Guy’s and St. Thomas’ NHS Foundation Trust

Rachel BastiaenenRachel Bastiaenen

Rachel is a Consultant Cardiologist at Guy’s and St Thomas’ NHS Foundation Trust where she is the Clinical Lead for Inherited Cardiac Conditions. She is also an Honorary Senior Lecturer at King’s College London.

She studied at Peterhouse Cambridge and Imperial College London. She completed Cardiology training in the London Deanery and a fellowship in Vancouver. Her PhD was awarded from St George’s University of London and involved non-invasive risk stratification of patients with cardiomyopathy. Her clinical and research interests focus on inherited arrhythmia syndromes, cardiomyopathies and cardiac MRI.

Elijah Behr

Elijah Behr

Elijah Behr is an international expert in the field of arrhythmias and is Professor in Cardiovascular Medicine at St George’s, University of London where he leads the Cardiology Research Section and Directs the Cardiovascular Clinical Academic Group. He is a Consultant Cardiologist and Electrophysiologist at St George’s University Hospitals NHS Foundation Trust and at Mayo Clinic Healthcare, London. He is a graduate of St John’s College, University of Cambridge and the University of London.

Professor Behr is past president of the Association for Inherited Cardiac Conditions and the first chairperson of the European Cardiac Arrhythmia Genetics Group of EHRA. He co-leads the arrhythmia syndrome sub-domain of the UK 100,000 Genomes Project Cardiovascular Genome England Clinical Interpretation Partnership and advise the NHS England Clinical Reference Groups for Cardiovasculr and Genomics Services. He leads the NHS England Coronial Sudden Unexpected Death Pilot.

He leads a research group with interests that include the genomics and prediction of sudden death risk; drug-induced arrhythmia; the Sudden Arrhythmic Death Syndrome (SADS) and Sudden Infant Death Syndrome (SIDS); channelopathies including long QT and Brugada syndromes; and arrhythmogenic cardiomyopathy.